XM does not provide services to residents of the United States of America.

Symrise posts higher half-year sales, matching estimates



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Symrise posts higher half-year sales, matching estimates</title></head><body>

Adds outlook in paragraph 4, CEO quote paragraph 5, context paragraph 6, division sales paragraph 7, Givaudan in paragraph 8

Aug 1 (Reuters) -German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line with expectations, driven by growth in both of its business areas.

Symrise's revenue rose to 2.57 billion euros ($2.78 billion)in the January-June period from 2.41 billion a year earlier. Analysts polled by Vara Research were expecting 2.56 billion euros on average.

Organic sales, which do not take currency exchange effects into account, increased by 11.5% in the same period.

Symrise, whose fragrances go into the perfumes of French luxury giants LVMH LVMH.PA and Kering PRTP.PA, reaffirmed its annual targets for organic sales growth of 5% to 7% and an EBITDA margin of around 20%.

"Despite our success in the first half of the year, we are not sitting back. Our good performance in recent months gives us confidence for the second half of the year," CEO Jean-Yves Parisot said in a statement.

Easing destocking trends are supporting flavour and fragrance makers' return to stable volumes, after a wave of inventory reductions and lower demand weighed on volumes throughout last year.

Half-year sales in the scent and care division, which makes fragrance applications, aroma chemicals and cosmetic ingredients, rose 12.1% in the reporting currency to 993 million euros. That was boosted by organic growth in a double-digit percentage at its fine fragrances and consumer fragrances units, it said.

Swiss rival Givaudan GIVN.S last week posted a 12.5% rise in its first-half sales on a like-for-like basis, although its second-quarter growth showed signs of stabilisation after a strong start to the year.

($1 = 0.9236 euros)



Reporting by Antonis Pothitos in Gdansk; Editing by Milla Nissi

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.